ABSTRACT. Several case-control studies have been conducted to investigate the association between the tumor necrosis factor-α (TNF-α)-308G/A polymorphism and vitiligo risk. However, the results of these studies are inconsistent; therefore, we attempted to comprehensively evaluate the association between TNF-α-308G/A polymorphism and vitiligo risk via a meta-analysis. Studies reporting the association between TNF-α-308G/A polymorphism and vitiligo risk were retrieved from PubMed and EmBase databases. Data were extracted from these studies and the pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the association. Six case-control studies including 1391 vitiligo cases and 2455 control subjects were included in this meta-analysis. The overall results showed the lack of a significant difference in TNF-α-308G/A genotype distribution between the patients and controls when the G allele and GG, GG + GA, GG, and GG genotypes were compared against the A allele and the GA + AA, AA, AA, and GA genotypes, respectively (ORs = 0.65, 0.53, 0.63, 0.41, 0.55; P = 0.188, 0.121, 0.627, 0.264, 0.135, respectively). This meta-analysis suggests that the TNF-α-308G/A polymorphism may not be associated with vitiligo risk. As few studies are available in this field and current evidence remains limited, these results must be corroborated with well-designed and larger studies in the future.
INTRODUCTION
Vitiligo is an acquired depigmenting skin disorder affecting approximately 0.5% of the world population (Taieb and Picardo, 2009) . Loss of functional melanocytes from the epidermis is the pathological hallmark of vitiligo. The etiopathogenesis of vitiligo is far from clear, but it has been associated with autoimmune processes (Bolognia and Pawelek, 1988; Ortonne and Bose, 1993; Kovacs, 1998) . Tumor necrosis factor (TNF)-α is a pleiotropic immunomodulator and pro-inflammatory cytokine that has been implicated in the pathogenesis of various kinds of autoimmune and inflammatory diseases, such as psoriasis, lepromatous leprosy, and systemic lupus erythematosus (Eigler et al., 1997; Roy et al., 1997; Sullivan et al., 1997; Kim et al., 2003) . Autoimmune disorders have been proposed as the possible pathogenesis of vitiligo, leading to an increasing number of studies focusing on the relationship between TNF-α expression and incidence of vitiligo. Previous in vitro studies have shown that TNF-α inhibits melanogenesis and promotes melanocyte apoptosis (Swope et al., 1991; Kim et al., 2007) . Several recent studies have shown the presence of increased tissue and serum levels of pro-inflammatory soluble mediators, including TNF-α, in vitiligo patients (Yu et al., 1997; Moretti et al., 2002; Tu et al., 2003) . Cases of vitiligo treated with TNF-α inhibitors, albeit achieving mixed results, have also been reported (Rigopoulos et al., 2007; Simon and Burgos-Vargas, 2008; Campanati et al., 2010) .
The promoter region of the TNF-α gene develops a number of polymorphisms (Allen, 1999; Brown, 2008) . The most common polymorphism occurs at position -308 (TNF-α-308G/A), which may affect the cytokine production (Wilson et al., 1997; Louis et al., 1998; Abraham and Kroeger, 1999) . A number of case-control studies have been conducted to investigate the association between the TNF-α-308G/A polymorphism and vitiligo risk (Yazici et al., 2006; Namian et al., 2009; Laddha et al., 2012; Salinas-Santander et al., 2012; Al-Harthi et al., 2013; Aydingoz et al., 2015) . However, the results of these studies have been inconsistent, which may be attributed to small sample sizes and the differences in ethnic populations. Therefore, in this study, we performed a meta-analysis to increase the statistical power of all eligible case-control analyses, and to obtain a precise estimate of the association between the TNF-α-308G/A polymorphism and vitiligo risk.
MATERIAL AND METHODS

Literature search
Studies reporting the association between TNF-α-308G/A polymorphism and vitiligo risk published up to March 31, 2015, were independently searched without language restrictions by two of the authors in the PubMed and EmBase databases, using the following keywords: "TNF-α" or "tumor necrosis factor-α"; "vitiligo"; and "polymorphism", "SNP", "single nucleotide polymorphism", "variation", or "mutation". The bibliographies of retrieved articles were then manually searched to find additional relevant studies.
Study selection
Studies meeting the following inclusion criteria were included in this meta-analysis: (a) evaluation of the TNF-α-308G/A polymorphism and vitiligo risk; (b) case-control studies; (c) availability of 95% confidence intervals (CIs) for odds ratios (ORs) (or possibility of calculation of the Cis); and (d) distribution of genotypes in the control group consistent with the Hardy-Weinberg equilibrium (HWE). Studies were excluded upon conformance with any of the following exclusion criteria: (a) reviews and abstracts; (b) genotype distributions not reported; and (c) family studies. If several articles were published by the same authors using the same patient data, only the study with the largest sample size or the most recent study was included.
Data extraction
The following data were independently extracted from the included studies by two of the authors: first author's name, publication date, population, sample size, genotyping method, genotype frequencies among the vitiligo patients and control subjects, and the p value of HardyWeinberg equilibrium (HWE) among the controls. Differences in opinion were resolved by discussion between the authors.
Statistical analysis
Genotype distributions in the controls were tested for HWE using Pearson's χ 2 -test (Schaid and Jacobsen, 1999) . Inter-study heterogeneity was analyzed using the Cochran Q-statistic and the I 2 test (Higgins and Thompson, 2002; Zintzaras and Ioannidis, 2005) . A random-effects model was used when P < 0.1 for the Q-test or I 2 > 50%, indicating heterogeneity; otherwise, a fixed-effects model was applied. ORs with corresponding 95%CIs were calculated to assess the association between the TNF-α-308G/A polymorphism and vitiligo risk in five genetic models (G allele vs A allele, GG vs GA + AA, GG + GA vs AA, GG vs AA, and GG vs GA). The significance of pooled ORs was determined using the Z-test. Begg's funnel plots and Egger's tests were used to determine the possible effect of a publication bias on the validity of the estimates; a p-value < 0.10 was considered to be significant (Peters et al., 2006) . All the statistical tests were conducted using STATA 12.0 software (StataCorp LP 4905 Lakeway Drive College Station, TX, USA).
RESULTS
Characteristics of included studies
The database search helped retrieve 32 potentially relevant studies from the PubMed and EmBase databases. In accordance with the inclusion criteria, six case-control studies comprising 1391 psoriasis cases and 2455 healthy controls were included in this meta-analysis. The distribution of genotypes in the control group of each included study was consistent with the HWE (all P > 0.05). Two investigators independently extracted the information from eligible studies, and a consensus was reached (Table 1) . 
Results of the meta-analysis
Significant inter-study heterogeneity was observed in all of the genetic models with the Q-test and the I 2 test (P < 0.1 or I 2 > 50%). Therefore, the random effects model was used to pool the results. The meta-analysis results identified the absence of any significant differences in the TNF-α-308G/A genotype distribution between the vitiligo patients and control subjects in the comparisons of the G allele vs the A allele, GG vs GA + AA, GG + GA vs AA, GG vs AA, and 
Publication bias
Begg's funnel plots and Egger's tests were used to assess the publication bias. As shown in Table 3 , most of the P values of Begg's funnel plots and Egger's tests were >0.10. However, the p values of the Egger's tests for G allele vs A allele and GG vs GA + AA were <0.10, indicating the presence of a significant publication bias in this meta-analysis. 
DISCUSSION
The TNF-α gene is located within the class III region of the gene coding for the major histocompatibility complex (MHC) on chromosome 6 (6p21.3) (Carroll et al., 1987) ; several single nucleotide polymorphisms (SNPs) have been identified in the promoter region (-162, -237, -238, -274, -308, -375, -575, -850, -857, and -863) of this gene (Allen, 1999; Brown, 2008) . Among these, a common polymorphism at position 308 (TNF-α-308G/A) has been studied intensively. The polymorphism appeared to influence TNF-α expression by interfering with the transcription factor binding sites or other regulatory elements; therefore, this polymorphism has been considered as a functional polymorphism (Wilson et al., 1992) . To date, several studies have been carried out to identify the potential role of TNF-α-308G/A polymorphism in increased vitiligo susceptibility. However, these studies have reported conflicting results. Some studies found a significant association between the TNF-α-308G/A polymorphism and vitiligo, whereas others failed to obtain any such association. Meta-analysis has been recognized as a useful statistical method that combines findings from independent studies to precisely evaluate the effect of selected genetic polymorphisms on the risk of disease (Attia et al., 2003) . To the best of our knowledge, no metaanalysis has been conducted to evaluate the association between the TNF-α-308G/A polymorphism and vitiligo risk. Therefore, there is a need to conduct a meta-analysis using published data to clarify the inconsistent findings in this field of study.
All studies included in this meta-analysis only analyzed genotypes for quality control. The genotype distribution of controls in all studies was consistent with the HWE. The results of this meta-analysis, performed using six case-control studies including 1391 vitiligo cases and 2455 healthy controls, revealed the lack of a significant difference in the TNF-α-308G/A genotype distribution between vitiligo patients and healthy controls, when the G allele and GG, GG + GA, GG, and GG genotypes were compared against the A allele and the GA+ AA, AA, AA, and GA genotypes, respectively. The results showed obvious heterogeneity between the studies, suggesting a possible role of ethnic and environmental differences in the genetic backgrounds. Some limitations of our meta-analysis should be acknowledged. First, some relevant studies could not be included in our analysis because of lack of complete raw data or publications. Second, the number of studies included was not sufficiently large and the sample size of some of the studies included was relatively small, which may result in insufficient statistical power to explore the real association between TNF-α-308G/A polymorphism and vitiligo risk. Third, the results of the Egger tests revealed the possibility of a significant publication bias in this meta-analysis. Moreover, vitiligo may also be modulated by several other genetic markers other than TNF-α, such as CYP2C9 (Alzolibani et al., 2014) , PTPN22 (Garcia-Melendez et al., 2014) , and ACE (Badran et al., 2015) . Therefore, the results of our metaanalysis emphasize the need for further evaluation of the potential gene-gene interactions in vitiligo, in order to elucidate the pathogenesis of vitiligo. Finally, some factors, such as the gender, age, and the clinical classification of the disease, were not considered when analyzing the data because of a lack of raw data, which may cause serious confounding bias. However, the advantages of this metaanalysis were also obvious. First, the sample size of our study was larger compared to that of the individual studies, which increased the reliability of the results. Second, the associations between TNF-α-308G/A polymorphism and vitiligo were evaluated under different genetic models.
In summary, this meta-analysis suggests that the TNF-α-308G/A polymorphism may not be associated with vitiligo risk. As few studies are available in this field and current evidence remains limited, further studies must be performed to warrant and validate our results.
